Splicing predictions reliably classify different types of alternative splicing

RNA

Volumn 21, Issue 5, 2015, Pages 813-823

  Busch, Anke ^a,b   Hertel, Klemens J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Institute of Molecular Biology (IMB)   (Germany)

Author keywords

Alternative splicing; Bioinformatics; Splicing predictor; Support vector machine

Indexed keywords

MESSENGER RNA; RNA; TRANS ACTING FACTOR; RNA SPLICING;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING SITE; EXON; HELA CELL LINE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; INTRON; PREDICTION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RNA SEQUENCE; SUPPORT VECTOR MACHINE; ANIMAL; BIOLOGY; GENETIC CODE; GENETICS; MAMMAL; PROCEDURES; REPRODUCIBILITY; RNA SPLICING; SEQUENCE ANALYSIS;

MAMMALIA;

ALTERNATIVE SPLICING; ANIMALS; COMPUTATIONAL BIOLOGY; EXONS; GENETIC CODE; HUMANS; MAMMALS; REPRODUCIBILITY OF RESULTS; RNA SPLICE SITES; SEQUENCE ANALYSIS, RNA;

EID: 84928034997     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.048769.114     Document Type: Article

References (55)

1. Ashiya M, Grabowski PJ. 1997. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. RNA 3: 996-1015.
2. Aznarez I, Barash Y, Shai O, He D, Zielenski J, Tsui LC, Parkinson J, Frey BJ, Rommens JM, Blencowe BJ. 2008. A systematic analysis of intronic sequences downstream of 5′ splice sites reveals a widespread role for U-rich motifs and TIA1/TIAL1 proteins in alternative splicing regulation. Genome Res 18: 1247-1258.
3. Barash Y, Calarco JA, Gao W, Pan Q, Wang X, Shai O, Blencowe BJ, Frey BJ. 2010. Deciphering the splicing code. Nature 465: 53-59.
4. Barash Y, Vaquero-Garcia J, González-Vallinas J, Xiong HY, Gao W, Lee LJ, Frey BJ. 2013. AVISPA: a web tool for the prediction and analysis of alternative splicing. Genome Biol 14: R114.
5. Barbosa-Morais NL, Irimia M, Pan Q, Xiong HY, Gueroussov S, Lee LJ, Slobodeniuc V, Kutter C, Watt S, Colak R, et al. 2012. The evolutionary landscape of alternative splicing in vertebrate species. Science 338: 1587-1593.
6. Bartel F, Harris LC, Würl P, Taubert H. 2004. MDM2 and its splice variant messenger RNAs: expression in tumors and down-regulation using antisense oligonucleotides. Mol Cancer Res 2: 29-35.
7. Berget SM. 1995. Exon recognition in vertebrate splicing. J Biol Chem 270: 2411-2414.
8. Black DL. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72: 291-336.
9. Brinkman BM. 2004. Splice variants as cancer biomarkers. Clin Biochem 37: 584-594.
10. Busch A, Hertel KJ. 2013. HEXEvent: a database of Human EXon splicing Events. Nucleic Acids Res 41: D118-D124.
11. Carstens RP, Eaton JV, Krigman HR, Walther PJ, Garcia-Blanco MA. 1997. Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer. Oncogene 15: 3059-3065.
12. Cartegni L, Chew SL, Krainer AR. 2002. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3: 285-298.
13. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. 2003. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31: 3568-3571.
14. Chen L, Zheng S. 2008. Identify alternative splicing events based on position-specific evolutionary conservation. PLoS One 3: e2806.
15. Clark F, Thanaraj TA. 2002. Categorization and characterization of transcript-confirmed constitutively and alternatively spliced introns and exons from human. Hum Mol Genet 11: 451-464.
16. Clouet d'Orval B, d'Aubenton Carafa Y, Sirand-Pugnet P, Gallego M, Brody E, Marie J. 1991. RNA secondary structure repression of a muscle-specific exon in HeLa cell nuclear extracts. Science 252: 1823-1828.
17. Dror G, Sorek R, Shamir R. 2005. Accurate identification of alternatively spliced exons using support vector machine. Bioinformatics 21: 897-901.
18. Eperon LP, Graham IR, Griffiths AD, Eperon IC. 1988. Effects of RNA secondary structure on alternative splicing of pre-mRNA: Is folding limited to a region behind the transcribing RNA polymerase? Cell 54: 393-401.
19. Faustino NA, Cooper TA. 2003. Pre-mRNA splicing and human disease. Genes Dev 17: 419-437.
20. Faustino NA, Cooper TA. 2005. Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment. Mol Cell Biol 25: 879-887.
21. Fox-Walsh KL, Hertel KJ. 2009. Splice-site pairing is an intrinsically high fidelity process. Proc Natl Acad Sci 106: 1766-1771.
22. Fox-Walsh KL, Dou Y, Lam BJ, Hung SP, Baldi PF, Hertel KJ. 2005. The architecture of pre-mRNAs affects mechanisms of splice-site pairing. Proc Natl Acad Sci 102: 16176-16181.
23. Galarneau A, Richard S. 2005. Target RNA motif and target mRNAs of the Quaking STAR protein. Nat Struct Mol Biol 12: 691-698.
24. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH. 2009. The WEKA data mining software: an update. ACM SIGKDD Explor Newsl 11: 10-18.
25. Hiller M, Zhang Z, Backofen R, Stamm S. 2007. Pre-mRNA secondary structures influence exon recognition. PLoS Genet 3: e204.
26. Ho TH, Charlet BN, Poulos MG, Singh G, Swanson MS, Cooper TA. 2004. Muscleblind proteins regulate alternative splicing. EMBO J 23: 3103-3112.
27. International Human Genome Sequencing Consortium. 2004. Finishing the euchromatic sequence of the human genome. Nature 431: 931-945.
28. Katz Y, Wang ET, Airoldi EM, Burge CB. 2010. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 7: 1009-1015.
29. Kornblihtt AR. 2005. Promoter usage and alternative splicing. Curr Opin Cell Biol 17: 262-268.
30. Krawczak M, Reiss J, Cooper DN. 1992. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90: 41-54.
31. Lorenz R, Bernhart SH, Höner Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL. 2011. ViennaRNA Package 2.0. Algorithms Mol Biol 6: 26.
32. McManus CJ, Graveley BR. 2011. RNA structure and the mechanisms of alternative splicing. Curr Opin Genet Dev 21: 373-379.
33. Mercatante DR, Bortner CD, Cidlowski JA, Kole R. 2001. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death. J Biol Chem 276: 16411-16417.
34. Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, et al. 2013. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 41: D64-D69.
35. Minovitsky S, Gee SL, Schokrpur S, Dubchak I, Conboy JG. 2005. The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons. Nucleic Acids Res 33: 714-724.
36. Oberstrass FC, Auweter SD, Erat M, Hargous Y, Henning A, Wenter P, Reymond L, Amir-Ahmady B, Pitsch S, Black DL, et al. 2005. Structure of PTB bound to RNA: specific binding and implications for splicing regulation. Science 309: 2054-2057.
37. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. 2008. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40: 1413-1415.
38. Pérez I, Lin CH, McAfee JG, Patton JG. 1997. Mutation of PTB binding sites causes misregulation of alternative 3′ splice site selection in vivo. RNA 3: 764-778.
39. Pickrell JK, Pai AA, Gilad Y, Pritchard JK. 2010. Noisy splicing drives mRNA isoform diversity in human cells. PLoS Genet 6: e1001236.
40. Platt JC. 1999. Fast training of support vector machines using sequential minimal optimization. MIT Press, Cambridge, MA.
41. Shepard PJ, Hertel KJ. 2008. Conserved RNA secondary structures promote alternative splicing. RNA 14: 1463-1469.
42. Shepard PJ, Hertel KJ. 2010. Embracing the complexity of pre-mRNA splicing. Cell Res 20: 866-868.
43. Shepard PJ, Choi EA, Busch A, Hertel KJ. 2011. Efficient internal exon recognition depends on near equal contributions from the 3′ and 5′ splice sites. Nucleic Acids Res 39: 8928-8937.
44. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, Clawson H, Spieth J, Hillier LW, Richards S, et al. 2005. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15: 1034-1050.
45. Sorek R, Ast G. 2003. Intronic sequences flanking alternatively spliced exons are conserved between human and mouse. Genome Res 13: 1631-1637.
46. Sorek R, Shemesh R, Cohen Y, Basechess O, Ast G, Shamir R. 2004. A non-EST-based method for exon-skipping prediction. Genome Res 14: 1617-1623.
47. Stamm S, Zhu J, Nakai K, Stoilov P, Stoss O, Zhang MQ. 2000. An alternative-exon database and its statistical analysis. DNA Cell Biol 19: 739-756.
48. Ule J, Stefani G, Mele A, Ruggiu M, Wang X, Taneri B, Gaasterland T, Blencowe BJ, Darnell RB. 2006. An RNA map predicting Nova-dependent splicing regulation. Nature 444: 580-586.
49. Wang Z, Lo HS, Yang H, Gere S, Hu Y, Buetow KH, Lee MP. 2003. Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res 63: 655-657.
50. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
51. Xiong HY, Barash Y, Frey BJ. 2011. Bayesian prediction of tissue-regulated splicing using RNA sequence and cellular context. Bioinformatics 27: 2554-2562.
52. Xu Q, Lee C. 2003. Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res 31: 5635-5643.
53. Yeo G, Burge CB. 2004. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 11: 377-394.
54. Yeo GW, Van Nostrand EL, Liang TY. 2007. Discovery and analysis of evolutionarily conserved intronic splicing regulatory elements. PLoS Genet 3: e85.
55. Zheng CL, Fu XD, Gribskov M. 2005. Characteristics and regulatory elements defining constitutive splicing and different modes of alternative splicing in human and mouse. RNA 11: 1777-1787.